What HIV parts should be the basis of a vaccine? How should they be presented to the immune system?
Cohen
J
J
D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D005818:Genetic Engineering; D006678:HIV / Q000235:genetics / Q000276:immunology; D015483:HIV Antibodies / Q000096:biosynthesis; D000882:Haplorhini; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D014613:Vaccines, Attenuated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D016915:AIDS Vaccines; D015483:HIV Antibodies; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic